Commercial Hormone Replacement Therapy Jeopardized Proinflammatory Factors in Experimental Rat Models

Hormone replacement therapy.

HRT is indicated for the treatment of moderate ▪ to severe vasomotor and urogenital symptoms associated with menopause. HRT is not recommended for primary prevention of ▪ disease because of increased risk of other adverse events. The use of HRT increases the risk of stroke, venous ▪ thromboembolism (VTE) and gall bladder disease and combined oestrogen progestogen therapy is also associated with...

Hormone replacement therapy.

Perspectives in hormone replacement therapy.

Estrogens have been convincingly shown to be highly effective in preventing and reversing menopause-related conditions, such as hot flushes, urogenital complaints, and postmenopausal bone loss. Observational studies report that long-term, estrogen-containing, postmenopausal hormone replacement therapy (HRT) leads to a substantial reduction in hip fractures, myocardial infarction, and possibly c...

Hormone Replacement Therapy in Menopause

The menopause is understood like a menstruation cease, because of sudden fall in hormone production. Generally, the symptoms at this stage are heat waves, lack of vaginal lubrication, loss of skin elasticity, hormonal changes, intensification of bone decalcification and reduction of libido. In order to alleviate these symptoms there are Hormone Replacement Therapies (HRT) that use synthetic dru...

Postmenopausal hormone replacement therapy.

Several comprehensive accounts of postmenopausal hormone replacement treatment have been published in the United Kingdom in the past year`so in this review we concentrate on areas which, while often controversial, are of concern to the practising physician. We discuss the effects of postmenopausal hormone replacement therapy on the risks of developing coronary heart disease, osteoporosis, and c...